Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has provided an update.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited has approved a Board Diversity Policy to enhance corporate governance and support sustainable development. This policy emphasizes the importance of diversity in the boardroom, considering factors such as gender, age, cultural background, and professional experience in the selection of board members. The Nomination and Remuneration Committee is tasked with ensuring the implementation of this policy, with the aim of achieving a balanced and effective board composition. The company will report annually on the board’s diversity and the policy’s implementation, reflecting its commitment to inclusivity and strategic growth.
The most recent analyst rating on (HK:0874) stock is a Buy with a HK$20.00 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is committed to enhancing its corporate governance and promoting sustainable development within the industry.
Average Trading Volume: 1,602,703
Technical Sentiment Signal: Buy
Current Market Cap: HK$43.28B
See more data about 0874 stock on TipRanks’ Stock Analysis page.